Piper Sandler Maintains Overweight on Claritev, Raises Price Target to $86
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Piper Sandler analyst Jessica Tassan maintains Claritev (NYSE:CTEV) with a Overweight and raises the price target from $44 to $86.
Piper Sandler analyst Jessica Tassan maintains Claritev (NYSE:CTEV) with a Overweight and raises the price target from $44 to $86.